Moreover, tumor-infiltrating anti-viral bystander CD8+ TILs expose a distinctive CD8+ T cell effector subtype composition with a diminished SLEC proportion compared to tumor-restricted OVA-specific CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.